This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Claudia Zylberberg
CEO at Akron Biotech


Claudia Zylberberg, Ph.D. is a leader in regenerative medicine. She is the founder and CEO of Akron Biotechnology, a manufacturer of cGMP-grade ancillary materials for the tissue, cell and gene therapy industry. She also co-founded AssureImmune, an adult stem cell bank. Dr. Zylberberg holds numerous patents and has developed several patent-pending platform technologies in cryopreservation, novel formulations and others. She has authored and co-authored several peer-reviewed publications and has received grants from the NIH and Department of Defense, among others. In her early years, Dr. Zylberberg worked at Nabi Biopharmaceuticals, specializing in human plasma-derived products. Her experience in product development and protein manufacturing has been instrumental for the development of key materials to accelerate the regen med industry. In addition, she co-founded the Standards Coordinating Body (SCB) and is a board member of ISCT, ARM, AABB’s NBF, and the NAS (Regenerative Medicine Forum). Other advisory positions include ISO US TAG, BioFlorida, ISSCR, CBA, and Biomedical Engineering, University of Miami.

Agenda Sessions

  • Advancing ATMP’s Manufacturing: Risks and Opportunities on Next Generation Ancillary Materials

    On Demand

Speakers at this event